Mai Hazekawa, Takuya Nishinakagawa, Masato Hosokawa, & Daisuke Ishibashi. (2022). Development of an Organ-Directed Exosome-Based siRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis Model. MDPI AG.
Chicago Style (17th ed.) CitationMai Hazekawa, Takuya Nishinakagawa, Masato Hosokawa, and Daisuke Ishibashi. Development of an Organ-Directed Exosome-Based SiRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis Model. MDPI AG, 2022.
MLA (9th ed.) CitationMai Hazekawa, et al. Development of an Organ-Directed Exosome-Based SiRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis Model. MDPI AG, 2022.